OSE Immunotherapeutics
OSE | PA
Overview
Corporate Details
- ISIN(s):
- FR0012127173 (+2 more)
- LEI:
- 969500HIUWVGY6NZSM05
- Country:
- France
- Address:
- 22 BOULEVARD BENONI GOULLIN, 44200 NANTES
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 70 employees and is listed on Euronext Paris.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-20 19:30 |
Inside Information Statement
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene…
|
English | 226.5 KB | |
| 2025-06-20 19:30 |
Inside Information Statement
OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale …
|
French | 204.2 KB | |
| 2025-06-11 18:30 |
General Meeting Notice
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
|
French | 201.6 KB | |
| 2025-06-11 18:30 |
General Meeting Notice
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
|
English | 204.6 KB | |
| 2025-06-09 08:00 |
Declaration of Voting Results & Voting Rights Announcements
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
|
French | 178.6 KB | |
| 2025-06-09 08:00 |
Declaration of Voting Results & Voting Rights Announcements
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
|
English | 184.3 KB | |
| 2025-06-05 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations relatives au nombre total de droits de vote et d’actions composan…
|
French | 196.4 KB | |
| 2025-06-04 08:00 |
General Meeting Notice
Ose Immunotherapeutics : Mise à disposition des documents préparatoires à l’Ass…
|
French | 174.9 KB | |
| 2025-06-04 08:00 |
Business and Financial Review
OSE Immunotherapeutics renforce sa stratégie de croissance : Accélération des …
|
French | 791.9 KB | |
| 2025-06-04 08:00 |
General Meeting Notice
Ose Immunotherapeutics : Documents made available to the shareholders for the c…
|
English | 222.3 KB | |
| 2025-06-04 08:00 |
Regulatory News Service
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of…
|
English | 290.7 KB | |
| 2025-06-02 18:00 |
Regulatory News Service
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Va…
|
English | 333.0 KB | |
| 2025-06-02 18:00 |
Regulatory News Service
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le can…
|
French | 311.0 KB | |
| 2025-05-23 07:00 |
Report Publication Announcement
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présente…
|
French | 293.3 KB | |
| 2025-05-23 07:00 |
Regulatory News Service
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Pre…
|
English | 264.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-19 | N/A | Other | Other | 10,000 | 35,700.00 EUR |
| 2024-06-17 | N/A | Other | Other | 10,000 | 35,800.00 EUR |
| 2024-06-17 | N/A | Other | Other | 10,000 | 35,700.00 EUR |
| 2024-06-13 | N/A | Other | Sell | 6,369 | 45,879.09 EUR |
| 2024-06-03 | N/A | Other | Sell | 40,000 | 314,512.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |